{"id":"https://openalex.org/W131635192","doi":"https://doi.org/10.1176/jnp.8.2.223","title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","display_name":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","alternate_titles":[],"publication_year":1996,"publication_date":"1996-05-01","ids":{"openalex":"https://openalex.org/W131635192","doi":"https://doi.org/10.1176/jnp.8.2.223","mag":"131635192","pmid":"https://pubmed.ncbi.nlm.nih.gov/9081563"},"language":"en","primary_location":{"id":"doi:10.1176/jnp.8.2.223","doi":"https://doi.org/10.1176/jnp.8.2.223","is_oa":false,"landing_page_url":"https://doi.org/10.1176/jnp.8.2.223","pdf_url":null,"source":{"id":"https://openalex.org/S50352613","display_name":"Journal of Neuropsychiatry","issn_l":"0895-0172","issn":["0895-0172","1545-7222"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4320800570","host_organization_name":"American Psychiatric Association Publishing","host_organization_lineage":["https://openalex.org/P4320800570","https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association Publishing","American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Neuropsychiatry and Clinical Neurosciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W131635192"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062393785","display_name":"Ian Creese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I Creese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159866109","display_name":"D R Burt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D R Burt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5159752854","display_name":"S H Snyder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S H Snyder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0834,"has_fulltext":false,"cited_by_count":117,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.75019258,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"8","issue":"2","first_page":"223","last_page":"226"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8604000210762024,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8604000210762024,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.12729999423027039,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-receptors","display_name":"dopamine receptors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8050000071525574},{"id":"https://openalex.org/keywords/receptor-binding-assay","display_name":"receptor binding assay","score":0.5509999990463257},{"id":"https://openalex.org/keywords/butyrophenones","display_name":"butyrophenones","score":0.8299999833106995},{"id":"https://openalex.org/keywords/phenothiazines","display_name":"phenothiazines","score":1.0},{"id":"https://openalex.org/keywords/postsynaptic-dopamine-receptors","display_name":"postsynaptic dopamine receptors","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.8053680658340454},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.684043288230896},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6401329040527344},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.6383669376373291},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.544011116027832},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.5392616391181946},{"id":"https://openalex.org/C197341189","wikidata":"https://www.wikidata.org/wiki/Q863533","display_name":"Postsynaptic potential","level":3,"score":0.5180580615997314},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.46820834279060364},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4502909183502197},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24867847561836243},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21512717008590698},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20967239141464233}],"mesh":[{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002090","descriptor_name":"Butyrophenones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002090","descriptor_name":"Butyrophenones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010640","descriptor_name":"Phenothiazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010640","descriptor_name":"Phenothiazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1176/jnp.8.2.223","doi":"https://doi.org/10.1176/jnp.8.2.223","is_oa":false,"landing_page_url":"https://doi.org/10.1176/jnp.8.2.223","pdf_url":null,"source":{"id":"https://openalex.org/S50352613","display_name":"Journal of Neuropsychiatry","issn_l":"0895-0172","issn":["0895-0172","1545-7222"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4320800570","host_organization_name":"American Psychiatric Association Publishing","host_organization_lineage":["https://openalex.org/P4320800570","https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association Publishing","American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Neuropsychiatry and Clinical Neurosciences","raw_type":"journal-article"},{"id":"pmid:9081563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9081563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of neuropsychiatry and clinical neurosciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1969473574","https://openalex.org/W1993949623","https://openalex.org/W1998063991","https://openalex.org/W2006122360","https://openalex.org/W2025160443","https://openalex.org/W2036011129","https://openalex.org/W2059916690"],"related_works":["https://openalex.org/W2046291435","https://openalex.org/W4405070580","https://openalex.org/W2092416470","https://openalex.org/W2048024192","https://openalex.org/W2409296493","https://openalex.org/W7098706847","https://openalex.org/W2033511385","https://openalex.org/W1968987074","https://openalex.org/W1991771532","https://openalex.org/W46061604"],"abstract_inverted_index":{"Tritiated":[0],"haloperidol":[1,28],"and":[2,17],"tritiated":[3,27],"dopamine":[4,7],"label":[5],"postsynaptic":[6],"receptors":[8],"in":[9,36],"mammalian":[10],"brain.":[11],"Clinical":[12],"potencies":[13],"of":[14],"butyrophenones,":[15],"phenothiazines,":[16],"related":[18],"drugs":[19,42],"correlate":[20],"closely":[21],"with":[22],"their":[23],"ability":[24],"to":[25],"inhibit":[26],"binding.":[29],"These":[30],"binding":[31],"methods":[32],"provide":[33],"a":[34],"simple":[35],"vitro":[37],"means":[38],"for":[39],"evaluating":[40],"new":[41],"as":[43],"potential":[44],"antischizophrenic":[45],"agents.":[46]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W131635192","counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
